Group One Trading
SGMT icon

Group One Trading’s Sagimet Biosciences SGMT Stock Holding History

Group One Trading’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Sell
36,000
-21,200
-37% -$118K ﹤0.01% 4159
2025
Q4 		$339K Sell
57,200
-50,000
-47% -$359K ﹤0.01% 3895
2025
Q3 		$735K Buy
107,200
+43,900
+69% +$356K ﹤0.01% 3311
2025
Q2 		$482K Buy
63,300
+29,600
+88% +$125K ﹤0.01% 3462
2025
Q1 		$110K Buy
33,700
+31,200
+1,248% +$131K ﹤0.01% 4530
2024
Q4 		$11.3K Buy
+2,500
New +$12.7K ﹤0.01% 6043

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Group One Trading's SGMT Position: Q1 2026 in Review

Group One Trading opened a new position in Sagimet Biosciences (SGMT) in Q1 2026: 13,061 shares worth $68.2K. The stake represents ﹤0.01% of the portfolio and ranks #5032 among its holdings. This is a return to the name: Group One Trading previously reported a position in SGMT as recently as Q3 2024.

Group One Trading first reported a position in SGMT in Q3 2024 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Group One Trading held 13,061 shares of Sagimet Biosciences worth $68.2K as of Q1 2026.
  • Sagimet Biosciences was a new Group One Trading position in Q1 2026.
  • Sagimet Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5032 holding.
  • Group One Trading first reported a position in Sagimet Biosciences in Q3 2024 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.